Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 9 studies | 38% ± 18% | |
retinal cone cell | 6 studies | 36% ± 16% | |
pericyte | 5 studies | 54% ± 23% | |
retinal pigment epithelial cell | 4 studies | 39% ± 9% | |
smooth muscle cell | 4 studies | 53% ± 22% | |
astrocyte | 4 studies | 23% ± 5% | |
endocardial cell | 3 studies | 45% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
heart | 5 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 95% | 975.28 | 232 / 245 | 100% | 9.48 | 502 / 502 |
brain | 78% | 414.25 | 2052 / 2642 | 79% | 14.90 | 557 / 705 |
lung | 86% | 482.51 | 499 / 578 | 63% | 1.51 | 724 / 1155 |
ovary | 100% | 5629.99 | 180 / 180 | 28% | 0.72 | 121 / 430 |
liver | 63% | 256.58 | 143 / 226 | 65% | 1.91 | 262 / 406 |
bladder | 81% | 985.86 | 17 / 21 | 35% | 1.21 | 177 / 504 |
esophagus | 79% | 948.97 | 1144 / 1445 | 23% | 0.53 | 43 / 183 |
heart | 100% | 6008.12 | 861 / 861 | 0% | 0 | 0 / 0 |
intestine | 71% | 969.53 | 685 / 966 | 29% | 0.90 | 152 / 527 |
breast | 53% | 187.60 | 242 / 459 | 38% | 0.88 | 422 / 1118 |
thymus | 35% | 104.17 | 227 / 653 | 49% | 2.28 | 296 / 605 |
adipose | 78% | 388.78 | 937 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 73% | 1198.04 | 976 / 1335 | 0% | 0 | 0 / 0 |
stomach | 37% | 298.00 | 132 / 359 | 35% | 0.97 | 99 / 286 |
pancreas | 0% | 0.73 | 1 / 328 | 69% | 2.45 | 122 / 178 |
adrenal gland | 19% | 50.07 | 48 / 258 | 49% | 1.41 | 113 / 230 |
skin | 11% | 29.24 | 190 / 1809 | 35% | 3.80 | 163 / 472 |
uterus | 28% | 90.06 | 48 / 170 | 14% | 0.80 | 63 / 459 |
kidney | 0% | 0 | 0 / 89 | 18% | 0.38 | 162 / 901 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.24 | 5 / 29 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.20 | 7 / 45 |
eye | 0% | 0 | 0 / 0 | 14% | 0.44 | 11 / 80 |
spleen | 8% | 25.03 | 19 / 241 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.27 | 1 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.20 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010744 | Biological process | positive regulation of macrophage derived foam cell differentiation |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_1903028 | Biological process | positive regulation of opsonization |
GO_0019370 | Biological process | leukotriene biosynthetic process |
GO_0090265 | Biological process | positive regulation of immune complex clearance by monocytes and macrophages |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0034638 | Biological process | phosphatidylcholine catabolic process |
GO_0034374 | Biological process | low-density lipoprotein particle remodeling |
GO_0090385 | Biological process | phagosome-lysosome fusion |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_0035965 | Biological process | cardiolipin acyl-chain remodeling |
GO_1905036 | Biological process | positive regulation of antifungal innate immune response |
GO_1905164 | Biological process | positive regulation of phagosome maturation |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0010518 | Biological process | positive regulation of phospholipase activity |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0050482 | Biological process | arachidonic acid secretion |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0032009 | Cellular component | early phagosome |
GO_0055037 | Cellular component | recycling endosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0032010 | Cellular component | phagolysosome |
GO_0047498 | Molecular function | calcium-dependent phospholipase A2 activity |
GO_0005543 | Molecular function | phospholipid binding |
GO_0047499 | Molecular function | calcium-independent phospholipase A2 activity |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | PLA2G5 |
Protein name | Phospholipase A2 group V (EC 3.1.1.4) (PLA2-10) (Phosphatidylcholine 2-acylhydrolase 5) |
Synonyms | |
Description | FUNCTION: Secretory calcium-dependent phospholipase A2 that primarily targets extracellular phospholipids . Hydrolyzes the ester bond of the fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity), preferentially releasing fatty acyl groups with a low degree of unsaturation such as oleoyl (C18:1) and linoleoyl (C18:2) groups . Hydrolyzes low-density lipoprotein (LDL) phospholipids releasing unsaturated fatty acids that drive macrophage polarization toward an M2 phenotype (By similarity). May act in an autocrine and paracrine manner. Contributes to lipid remodeling of cellular membranes at different subcellular locations and generation of lipid mediators involved in pathogen clearance. Cleaves sn-2 fatty acyl chains of cardiolipin, a major component of the inner membrane of mitochondria and bacterial membranes . Promotes phagocytosis of bacteria in macrophages through production of lysophosphatidylethanolamines . Displays bactericidal activity against Gram-positive bacteria by directly hydrolyzing phospholipids of the bacterial membrane . Promotes phagocytosis and killing of ingested fungi likely through controlling phagosome-lysosome fusion and phagosome maturation (By similarity). Plays a role in biosynthesis of cysteinyl leukotrienes (CysLTs) in myeloid cells . In eosinophils, triggers perinuclear arachidonate release and LTC4 synthesis in a PLA2G4A-independent way . In neutrophils, amplifies CysLTs biosynthesis initiated by PLA2G4A . Promotes immune complex clearance in macrophages via stimulating synthesis of CysLTs, which act through CYSLTR1 to trigger phagocytosis (By similarity). May regulate antigen processing in antigen-presenting cells (By similarity). In pulmonary macrophages regulates IL33 production required for activation of group 2 innate lymphoid cells (By similarity). May play a role in the biosynthesis of N-acyl ethanolamines that regulate energy metabolism. Hydrolyzes N-acyl phosphatidylethanolamines to N-acyl lysophosphatidylethanolamines, which are further cleaved by a lysophospholipase D to release N-acyl ethanolamines . . |
Accessions | ENST00000375108.4 P39877 |